Teladoc CAO sells shares to cover RSU taxes

Teladoc Health, Inc. Chief Accounting Officer Joseph Ronald Catapano reported the vesting of restricted stock units and a related share sale.

Accepted by SEC EDGAR 07/06/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Teladoc Health, Inc. Chief Accounting Officer Joseph Ronald Catapano reported the vesting of restricted stock units and a related share sale. On July 1, 2026, 2,083 restricted stock units converted into the same number of common shares at a conversion price of $0.00 per share. According to the footnotes, these units convert to Teladoc common stock on a one-for-one basis and relate to a 25,000-unit grant awarded on October 1, 2024.

On July 2, 2026, 653 common shares were sold at $9.10 per share. A footnote explains that these shares were sold to cover the tax withholding obligation arising from the RSU vesting, indicating a compensation-related, non-discretionary sale rather than an ordinary portfolio transaction. Following these transactions, Catapano directly holds 12,267 Teladoc common shares, and 10,418 restricted stock units remain outstanding.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Catapano Joseph Ronald

Role Chief Accounting Officer

Sold 653 shs ($6K)

Approx. gross sale proceeds $6K

Approx. exercise cost $0.00

Share of Position Sold 5.1%

Type	Security	Shares	Price	Value
Sale	Common Stock	653	$9.10	$6K
Exercise	Restricted Stock Units	2,083	$0.00	$0.00
Exercise	Common Stock	2,083	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 10,418 contracts (Direct); Common Stock — 12,267 shares (Direct)

Holdings Before and After: Restricted Stock Units, 12,501 to 10,418 contracts (Direct); Common Stock, 10,837 to 12,267 shares (Direct)

Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (3)

1. F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis
2. F2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3. F3. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

Shares sold: 653 shares Sale price: $9.10/share RSUs vested: 2,083 units +3 more

6 metrics

Shares sold 653 shares Sold at $9.10 per share on July 2, 2026

Sale price $9.10/share Price for 653 Teladoc common shares sold

RSUs vested 2,083 units Restricted stock units converted to common stock on July 1, 2026

Shares held after 12,267 shares Direct Teladoc common stock ownership following transactions

RSUs remaining 10,418 units Restricted stock units outstanding after the July 1, 2026 vesting

Original RSU grant 25,000 units Grant on October 1, 2024 with staged vesting schedule

Key Terms

Restricted stock units, open-market sale, derivative security, tax withholding obligation

4 terms

Restricted stock units financial

"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

tax withholding obligation financial

"Shares sold to cover the tax withholding obligation in respect of vesting"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Teladoc (TDOC) report for Joseph Ronald Catapano?

Teladoc’s Chief Accounting Officer reported RSU vesting and a related tax sale. 2,083 restricted stock units converted into common shares, and 653 shares were sold, primarily to satisfy tax withholding obligations tied to the vesting event.

How many Teladoc (TDOC) shares did the CAO sell and at what price?

Joseph Ronald Catapano sold 653 Teladoc common shares at $9.10 per share. A filing footnote states the sale’s purpose was covering tax withholding from restricted stock unit vesting, rather than a discretionary portfolio sale.

How many Teladoc (TDOC) restricted stock units vested in this Form 4 filing?

The filing shows 2,083 restricted stock units converted into an equal number of Teladoc common shares. These units are part of a 25,000-unit RSU grant from October 1, 2024, vesting over time under a defined anniversary and quarterly schedule.

What are Joseph Ronald Catapano’s Teladoc (TDOC) holdings after these transactions?

After the reported transactions, Catapano directly holds 12,267 Teladoc common shares. In addition, 10,418 restricted stock units remain outstanding, which can convert into common shares in future vesting events under the original award terms.

Was the Teladoc (TDOC) insider share sale part of regular compensation tax withholding?

Yes. A footnote explains the 653 Teladoc shares were sold to cover tax withholding obligations on vested restricted stock units. This characterizes the sale as compensation-related and mechanistic, not a discretionary decision to reduce overall equity exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Catapano Joseph Ronald

(Last) (First) (Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		M		2,083	A	(1)	12,920	D
Common Stock	07/02/2026		S		653(2)	D	$9.1	12,267	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/01/2026		M			2,083	(3)	(3)	Common Stock	2,083	$0	10,418	D

Explanation of Responses:

1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis

2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

3. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)